Key Insights

Highlights

Success Rate

91% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.3%

2 terminated out of 32 trials

Success Rate

91.3%

+4.8% vs benchmark

Late-Stage Pipeline

19%

6 trials in Phase 3/4

Results Transparency

10%

2 of 21 completed with results

Key Signals

2 with results91% success

Data Visualizations

Phase Distribution

28Total
Not Applicable (20)
P 1 (2)
P 3 (1)
P 4 (5)

Trial Status

Completed21
Unknown4
Recruiting3
Terminated2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

91.3%

Benchmark: 86.5%

Based on 21 completed trials

Clinical Trials (32)

Showing 20 of 20 trials
NCT06275906Not ApplicableCompleted

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

NCT06389851Not ApplicableCompleted

Effects of Tomato Consumption on Steatosis, Intestinal Function and Glucose and Lipid Metabolism in Subjects With NAFLD

NCT05815602Phase 3Recruiting

Ebastine Versus Mebeverine in IBS Patients

NCT01912313Not ApplicableRecruitingPrimary

Measuring Nerve Activity in Small Human Intestinal Biopsies in IBS (Irritable Bowel Syndrome)

NCT05995899Phase 4CompletedPrimary

Effect of Tenapanor on the Metagenomics and Metabolomics of Patients With Irritable Bowel Syndrome With Constipation

NCT07426705Phase 4Not Yet Recruiting

Effect of Multispecies Probiotic Supplementation on the Efficacy of Rifaximin α Therapy in Patients With Small Intestinal Bacterial Overgrowth (SIBO): a Randomized Placebo-controlled Trial

NCT06618677Not ApplicableCompletedPrimary

Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome

NCT02920268Not ApplicableCompleted

Just in TIME - Intervention With Dance and Yoga for Girls With Recurrent Abdominal Pain

NCT02981888CompletedPrimary

Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome

NCT04953728Not ApplicableCompletedPrimary

Optimization of Transcutaneous Electrical Acustimulation (TEA) Modalities for Treatment of IBS-C

NCT05718505Not ApplicableUnknown

Comparison of the Atmo Motility Gas Capsule System to the Reference Standard

NCT05579444Terminated

Systems Biology of Gastrointestinal and Related Diseases

NCT06072287Unknown

The Living With a Long-Term Condition Study

NCT05737277Not ApplicableUnknown

Gabapral in Pediatric IBS

NCT02421705Not ApplicableRecruitingPrimary

Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)

NCT02313207Not ApplicableWithdrawnPrimary

Confocal Laser Endomicroscopy in IBS Patients

NCT03986476Not ApplicableCompletedPrimary

The Effect of Two Probiotic Products on the Intestinal Barrier Function in Patients With Irritable Bowel Syndrome

NCT04677881Not ApplicableCompletedPrimary

Health Effects of Different Types of Bread

NCT03482765Not ApplicableCompletedPrimary

A Study of Probiotics in IBS Subjects

NCT00179582Not ApplicableTerminatedPrimary

Dose Ranging Study With the Probiotic Combination (VSL#3) in Diarrhea IBS

Scroll to load more

Research Network

Activity Timeline